Max Healthcare Institute Limited (BOM:543220)
India · Delayed Price · Currency is INR 1,098.55
-27.95 (-2.48%)
At close: Jul 31, 2026
Max Healthcare Institute Stock Forecast
Stock Price Forecast
According to 27 analysts polled by S&P Global, Max Healthcare Institute stock has a consensus rating of "Buy" and an average price target of ₹1,173. The average 1-year stock price forecast is 6.74% higher than the current stock price, while the lowest is ₹825.00 (-24.90%) and the highest is ₹1,370 (+24.71%).
Price Target: ₹1,173 (+6.74%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Max Healthcare Institute stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 13 | 12 | 12 | 12 |
| Buy | 7 | 7 | 7 | 7 | 7 | 8 |
| Hold | 3 | 2 | 2 | 3 | 3 | 3 |
| Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 25 | 25 | 26 | 26 | 26 | 27 |
Financial Forecast
Revenue This Year
117.17B
from 83.73B
Increased by 39.93%
Revenue Next Year
139.58B
from 117.17B
Increased by 19.12%
EPS This Year
19.58
from 15.18
Increased by 28.97%
EPS Next Year
24.28
from 19.58
Increased by 24.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.